Literature DB >> 6953445

Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved.

R A Larson, J Chung, A M Scanu, S Yachnin.   

Abstract

Human peripheral blood lymphocytes, in the presence of human neutrophils, initiate DNA synthesis and cell cycling when exposed to mevalonic acid. The ability of lymphocytes to respond in this manner is a radiosensitive property of cells, whereas the help provided by neutrophils is maintained despite their exposure to x-irradiation. Other organic acid anions, including precursors of mevalonic acid biosynthesis and a variety of products of mevalonate metabolism, fail to initiate DNA synthesis when added to human lymphocytes. Because only the metabolically active R(--) enantiomer of mevalonic acid initiates lymphocyte DNA synthesis, we presume that physiological pathways of mevalonate metabolism are involved. The response to mevalonic acid of ML-236B (compactin)-inhibited lymphocytes is increased, and the threshold concentration of meyalonate at which lymphocyte DNA synthesis first appears is decreased, when the cells are cultured in lipoprotein-containing (as opposed to lipoprotein-depleted) medium. The response to mevalonic acid of lymphocytes cultured in lipoprotein-depleted medium can be enhanced by addition to the cultures of low density lipoprotein but not by addition of high density lipoprotein. Based upon the flux diversion hypothesis of mevalonate metabolism, these observations suggest that a nonsterol product of mevalonate metabolism may be responsible for the initiation of lymphocyte DNA synthesis by mevalonic acid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953445      PMCID: PMC346342          DOI: 10.1073/pnas.79.9.3028

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.

Authors:  J L Goldstein; J A Helgeson; M S Brown
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

2.  Synthesis of ubiquinone and cholesterol in human fibroblasts: regulation of a branched pathway.

Authors:  J R Faust; J L Goldstein; M S Brown
Journal:  Arch Biochem Biophys       Date:  1979-01       Impact factor: 4.013

3.  Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum.

Authors:  A G Brown; T C Smale; T J King; R Hasenkamp; R H Thompson
Journal:  J Chem Soc Perkin 1       Date:  1976

4.  Purification of mitogenic proteins derived from Phaseolus vulgaris: isolation of potent and weak phytohemagglutinins possessing mitogenic activity.

Authors:  L W Allen; R H Svenson; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

5.  Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor.

Authors:  A J Habenicht; J A Glomset; R Ross
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

6.  Inhibition of human lymphocyte transformation by oxygenated sterol compounds.

Authors:  S Yachnin; R Hsu
Journal:  Cell Immunol       Date:  1980-04       Impact factor: 4.868

7.  Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.

Authors:  I Kaneko; Y Hazama-Shimada; A Endo
Journal:  Eur J Biochem       Date:  1978-06-15

8.  Essential role for mevalonate synthesis in DNA replication.

Authors:  V Quesney-Huneeus; M H Wiley; M D Siperstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Forms of human serum high density lipoprotein protein.

Authors:  A Scanu
Journal:  J Lipid Res       Date:  1966-03       Impact factor: 5.922

10.  Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development.

Authors:  S Yachnin
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

View more
  1 in total

1.  Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro.

Authors:  R A Larson; S Yachnin
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.